Fried Frank acted as counsel to Leerink Partners LLC as financial advisor to Cynosure, Inc. in its sale to Hologic, Inc. for US$66.00 per share in cash, an equity value of approximately US$1.65 billion. Cynosure has a broad portfolio of more than 20 products across major categories including non-invasive body contouring, hair removal, skin revitalization and women's health. Hologic is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products focused on women’s health. The transaction provides Hologic with entry into the large, fast-growing medical aesthetics segment and is expected to accelerate Hologic’s transformation into a higher-growth company.
The Fried Frank team included corporate partner Warren de Wied and corporate associate Elizabeth Kalenik.